Table 6 Serologies of ankylosing spondylitis patients and healthy controls stratified by fecal calprotectin
From: Markers of intestinal inflammation in patients with ankylosing spondylitis: a pilot study
|  | Healthy controls (all) compared with AS patients (fCAL cutoff 50 μg/g) | ||||
|---|---|---|---|---|---|
| Â | Median HC | Median AS fCAL-negative | Pvalue (HC versus fCAL-negative) | Median AS fCAL-positive | Pvalue (HC versus fCAL-positive) |
IgA ASCA (ELISA units) | 0.4 | 0.2 | 0.478 | 1.9 | 0.110 |
IgG ASCA (ELISA units) | 6.7 | 6.2 | 0.344 | 11.5 | 0.023 |
I2 (ELISA units) | 5.7 | 6.8 | 0.394 | 4 | 0.703 |
OmpC (ELISA units) | 5.7 | 6.1 | 0.904 | 8.4 | 0.240 |
Cbir1 Fla (ELISA units) | 15.9 | 16.2 | 0.659 | 27.2 | 0.003 |
ANCA (ELISA units) | 4.3 | 5 | 0.240 | 9.2 | < 0.001 |